WaiveDx Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

WaiveDx General Information

Description

Operator of a precision health technology platform intended to deliver personalized health outcomes across clinical and government markets. The company's platform automates clinical interpretation, regulatory compliance, genomic data management, and pharmacogenomic analysis, enabling healthcare providers and government programs to make faster, data-driven, personalized health decisions at scale.

Contact Information

Website
www.waivedx.ai
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 430 B Roper Mountain Road
  • Greenville, SC 29615
  • United States
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Parent Company
WellGenx
Corporate Office
  • 430 B Roper Mountain Road
  • Greenville, SC 29615
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

WaiveDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Feb-2026 Completed Generating Revenue
2. Merger/Acquisition 26-Aug-2025 Completed Generating Revenue
1. Joint Venture Completed Generating Revenue
To view WaiveDx’s complete valuation and funding history, request access »

WaiveDx Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Precision Genetics Corporation Minority
Waive IQ Corporation Minority
To view WaiveDx’s complete investors history, request access »

WaiveDx FAQs

  • Where is WaiveDx headquartered?

    WaiveDx is headquartered in Greenville, SC.

  • What industry is WaiveDx in?

    WaiveDx’s primary industry is Enterprise Systems (Healthcare).

  • Is WaiveDx a private or public company?

    WaiveDx is a Private company.

  • What is WaiveDx’s current revenue?

    The current revenue for WaiveDx is .

  • Who are WaiveDx’s investors?

    Precision Genetics and Waive IQ have invested in WaiveDx.

  • When was WaiveDx acquired?

    WaiveDx was acquired on 01-Feb-2026.

  • Who acquired WaiveDx?

    WaiveDx was acquired by WellGenx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process